Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.94
Delayed Data
As of Jul 20
 +0.32 / +0.51%
Today’s Change
57.18
Today|||52-Week Range
66.80
+6.91%
Year-to-Date

Today’s Trading

Previous close62.62
Today’s open62.91
Day’s range62.86 - 63.24
Volume6,655,095
Average volume (3 months)8,840,951
Market cap$172.2B
Dividend yield2.99%
Data as of 07/20/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+1.69%
Earnings growth (next 5 years)+6.20%
Revenue growth (last year)+1.86%
P/E ratio40.1
Price/Sales4.15
Price/Book4.32

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.08-0.24%
NVSNovartis+0.39+0.46%
SNYSanofi+1.25+2.67%
ABBVAbbVie+1.24+1.70%
Data as of 07/20/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$0.87
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts